Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling PathwayXiaozhong Liao, Lingling Sun, Jue Zhang et al.|Frontiers in Oncology|2020Cited by 19
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot StudyWenmin Chen, Lizhu Lin, Zhiwei Xiao et al.|Integrative Cancer Therapies|2023Cited by 6
Analysis of prescription regularity of traditional Chinese medicine for colorectal cancer based on data miningXiangjun Qi, Lizhu Lin, Jiahao Mo et al.|China Journal of Chinese Materia Medica|2021Cited by 5
Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trialJietao Lin, Lizhu Lin, Xiangjun Qi et al.|Journal of Thoracic Disease|2022Cited by 5